These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4948628)

  • 1. A metabolic and kinetic study on the association rifampicin-isoniazid.
    Acocella G
    Respiration; 1971; 28():Suppl:1-6. PubMed ID: 4948628
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological study of rifampicin after repeated high dosage during intermittent combined therapy. II. Bilirubin levels and other biochemical determinations.
    Verbist L; Rollier F
    Respiration; 1971; 28():Suppl:17-28. PubMed ID: 5150793
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease.
    Acocella G; Bonollo L; Garimoldi M; Mainardi M; Tenconi LT; Nicolis FB
    Gut; 1972 Jan; 13(1):47-53. PubMed ID: 5060669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of ketoconazole with rifampin and isoniazid.
    Engelhard D; Stutman HR; Marks MI
    N Engl J Med; 1984 Dec; 311(26):1681-3. PubMed ID: 6095080
    [No Abstract]   [Full Text] [Related]  

  • 5. [International Symposium on Rifampicin. Morning discussion].
    Respiration; 1971; 28():Suppl:52-6. PubMed ID: 5152423
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacodynamic interference between rifampicin and isoniazid.
    Llorens J; Serrano RJ; Sanchez R
    Chemotherapy; 1978; 24(2):97-103. PubMed ID: 620612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Australian rifampicin trial.
    Proust AJ
    Med J Aust; 1971 Jul; 2(2):85-94. PubMed ID: 4999365
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A; Bergogne-Berezin E; Lafaix C
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results and tolerance of prolonged rifampicin treatment in recent and chronic forms of pulmonary tuberculosis.
    Nitti V
    Respiration; 1971; 28():Suppl:57-69. PubMed ID: 4948629
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.
    Jenne JW; Beggs WH
    Am Rev Respir Dis; 1973 Jun; 107(6):1013-21. PubMed ID: 4197230
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoniazid plus rifampicin in the initial treatment of pulmonary tuberculosis.
    Clarke GB; Cuthbert J; Cuthbert RJ; Lees AW
    Br J Dis Chest; 1972 Oct; 66(4):268-71. PubMed ID: 5083434
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum concentrations and bioavailability of rifampicin and isoniazid in combination.
    Garnham JC; Taylor T; Turner P; Chasseaud LF
    Br J Clin Pharmacol; 1976 Oct; 3(5):897-902. PubMed ID: 973984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
    Pilheu JA; Galati MR; Yunis AS; De Salvo MC; Negroni R; García Fernández JC; Mingolla L; Rubio MC; Masana M; Acevedo C
    Medicina (B Aires); 1989; 49(1):43-7. PubMed ID: 2698437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients].
    Pilheu JA; De Salvo MC; Barcat JA
    Medicina (B Aires); 1979; 39(3):298-304. PubMed ID: 514051
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of different oral doses of isoniazid-rifampicin in rats.
    Rana SV; Pal R; Vaiphie K; Singh K
    Mol Cell Biochem; 2006 Sep; 289(1-2):39-47. PubMed ID: 16583132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some comparative aspects of rifampicin and isoniazid.
    Canetti G; Le Lirzin M; Porven G; Rist N; Grumbach F
    Tubercle; 1968 Dec; 49(4):367-76. PubMed ID: 4975544
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
    Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
    Zwolska Z; Niemirowska-Mikulska H; Augustynowicz-Kopec E; Walkiewicz R; Stambrowska H; Safianowska A; Grubek-Jaworska H
    Int J Tuberc Lung Dis; 1998 Oct; 2(10):824-30. PubMed ID: 9783530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R; Singh I; Kaur KJ; Kaul CL
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):625-8. PubMed ID: 10669909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma levels of rifampicin and isoniazid and serum levels of aminotransferases in combined tuberculostatic treatment (author's transl)].
    Knop P; Kindler U; Austerhoff A
    Dtsch Med Wochenschr; 1977 Dec; 102(52):1913-5. PubMed ID: 598300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.